ArticleBMC cancer2019

CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors.

Christian Daniel Fankhauser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.